Burden of disease and barriers to the diagnosis and treatment of group a beta-hemolytic streptococcal pharyngitis for the prevention of rheumatic heart disease in Dar Es Salaam, Tanzania

Pediatric Infectious Disease Journal

Volumn 29, Issue 12, 2010, Pages 1135-1137

  Bergmark, Regan ^a   Bergmark, Brian ^a   Blander, Jeffrey ^b,c   Fataki, Maulidi ^d   Janabi, Mohamed ^e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Bienmoyo Foundation   (United States)

^d Department of Pediatrics ^*  (Australia)

^e MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

rapid test; rheumatic fever; rheumatic heart disease; Streptococcus; Tanzania

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; CHILD; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PHARYNGITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; RHEUMATIC HEART DISEASE; SCHOOL CHILD; SORE THROAT; STREPTOCOCCUS INFECTION; TANZANIA;

ADOLESCENT; ADULT; ATTITUDE OF HEALTH PERSONNEL; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PHARYNGITIS; RHEUMATIC HEART DISEASE; STREPTOCOCCAL INFECTIONS; TANZANIA; YOUNG ADULT;

EID: 78650373736     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181edf475     Document Type: Article

References (12)

1. World Health Organization. Rheumatic fever and rheumatic heart disease. World Health Organ Tech Rep Ser. 2004;923:1-122.
2. Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685-694.
3. Soudarssanane MB, Karthigeyan M, Mahalakshmy T, et al. Rheumatic fever and rheumatic heart disease: primary prevention is the cost effective option. Indian J Pediatr. 2007;74:567-570.
4. Karthikeyan G, Mayosi BM. Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa? Circulation. 2009;120:709-713.
5. World Health Organization. WHO Statistical Information System Database, 2002 Statistics. February 6, 2009. Available at: www.who.int/whosis/en/. Accessed February 13, 2010.
6. Ash JS, Lyman J, Carpenter J, et al. A diffusion of innovations model of physician order entry. Proc AMIA Symp. 2001:22-26.
7. Fawzi WW, Msamanga GI, Spiegelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med. 2004;351:23-32.
8. Sanyal SK, Berry AM, Duggal S, et al. Sequelae of the initial attack of acute rheumatic fever in children from north India. A prospective 5-year follow-up study. Circulation. 1982;65:375-379.
9. Steer AC, Carapetis JR. Prevention and treatment of rheumatic heart disease in the developing world. Nat Rev Cardiol. 2009;6:689-698.
10. Lennon D, Stewart J, Farrell E, et al. School-based prevention of acute rheumatic fever: a group randomized trial in New Zealand. Pediatr Infect Dis J. 2009;28:787-794.
11. Lennon D, Kerdemelidis M, Arroll B. Meta-analysis of trials of strepto-coccal throat treatment programs to prevent rheumatic fever. Pediatr Infect Dis J. 2009;28:e259-e264.
12. Carapetis J, Steer A. Prevention of rheumatic fever. Pediatr Infect Dis J. 2010;29:91-92; author reply 92.